Purdue Allotted 10 Days For Ch. 11 Confirmation Trial

By Vince Sullivan · August 9, 2021, 4:18 PM EDT

OxyContin maker Purdue Pharma's Chapter 11 plan confirmation trial will be limited to 10 days, after a New York bankruptcy judge said Monday that objectors to the plan had requested far...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Purdue Pharma L.P.

Case Number

7:19-bk-23649

Court

New York Southern

Nature of Suit

Date Filed

September 15, 2019